advertisement

---

Chung Y 12

Showing records 1 to 12 | Display all abstracts from Chung Y

112340 A new model of axon degeneration in the mouse optic nerve using repeat intraocular pressure challenge
Chrysostomou V
Experimental Eye Research 2024; 238: 109722

---

112854 COMfort Eye Trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost versus a reference drug (Xalatan&re
Kandarakis S; Papadopoulos AP
Expert Opinion on Drug Safety 2023; 0: 1-12

---

112340 A new model of axon degeneration in the mouse optic nerve using repeat intraocular pressure challenge
Bell KC
Experimental Eye Research 2024; 238: 109722

---

112854 COMfort Eye Trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost versus a reference drug (Xalatan&re
Roussopoulos G
Expert Opinion on Drug Safety 2023; 0: 1-12

---

112340 A new model of axon degeneration in the mouse optic nerve using repeat intraocular pressure challenge
Ng SW
Experimental Eye Research 2024; 238: 109722

---

112854 COMfort Eye Trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost versus a reference drug (Xalatan&re
Georgopoulos E
Expert Opinion on Drug Safety 2023; 0: 1-12

---

112340 A new model of axon degeneration in the mouse optic nerve using repeat intraocular pressure challenge
Suresh S; Karthik G
Experimental Eye Research 2024; 238: 109722

---

112854 COMfort Eye Trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost versus a reference drug (Xalatan&re
Chung Y; Doumazos L
Expert Opinion on Drug Safety 2023; 0: 1-12

---

112340 A new model of axon degeneration in the mouse optic nerve using repeat intraocular pressure challenge
Millet M; Chung Y
Experimental Eye Research 2024; 238: 109722

---

112854 COMfort Eye Trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost versus a reference drug (Xalatan&re
Baek A; Paizi NI
Expert Opinion on Drug Safety 2023; 0: 1-12

---

112340 A new model of axon degeneration in the mouse optic nerve using repeat intraocular pressure challenge
Crowston JG
Experimental Eye Research 2024; 238: 109722

---

112854 COMfort Eye Trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost versus a reference drug (Xalatan&re
Shin H; Papadopoulos PA
Expert Opinion on Drug Safety 2023; 0: 1-12

---